BioLife Solutions, Inc.
BLFS
$23.95
-$0.79-3.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 24.69% | 63.91% | 31.21% | 28.94% | 19.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.69% | 63.91% | 31.21% | 28.94% | 19.64% |
| Cost of Revenue | 37.91% | 107.77% | 37.11% | 38.11% | 17.15% |
| Gross Profit | 18.22% | 45.59% | 28.09% | 24.43% | 20.91% |
| SG&A Expenses | 6.81% | 2.37% | 23.40% | 19.72% | 7.99% |
| Depreciation & Amortization | 28.79% | 103.69% | 2.34% | 3.66% | -90.41% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.82% | 70.56% | 29.10% | 26.27% | 3.80% |
| Operating Income | 105.41% | -114.76% | 78.71% | 14.09% | 84.86% |
| Income Before Tax | 337.89% | 312.58% | 227.59% | -182.64% | 108.96% |
| Income Tax Expenses | 342.86% | -820.83% | 202.50% | 12,500.00% | -17.65% |
| Earnings from Continuing Operations | 337.64% | 373.71% | 231.85% | -184.86% | 108.47% |
| Earnings from Discontinued Operations | -- | -25.41% | -- | -- | 89.76% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 364.73% | -11.16% | 136.47% | 23.56% | 95.62% |
| EBIT | 105.41% | -114.76% | 78.71% | 14.09% | 84.86% |
| EBITDA | 6,500.00% | -77.47% | -34.39% | -75.38% | 101.08% |
| EPS Basic | 357.89% | -13.93% | 135.23% | 26.42% | 95.78% |
| Normalized Basic EPS | 504.17% | 298.41% | 222.67% | 87.62% | 105.48% |
| EPS Diluted | 310.53% | -13.94% | 127.10% | 26.42% | 95.78% |
| Normalized Diluted EPS | 521.74% | 304.92% | 220.00% | 87.62% | 105.25% |
| Average Basic Shares Outstanding | 2.81% | 3.21% | 3.79% | 3.90% | 3.75% |
| Average Diluted Shares Outstanding | 1.82% | 2.03% | 5.52% | 3.90% | 6.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |